Clinical Trials Browser

Phase 1/2 × epratuzumab × Other hematologic neoplasm × Clear all

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01354457 2014-06-25

RIT 90YEpra

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma